reference/25111841

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25111841

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	714
issn	0278-0232 1099-1069
issueIdentifier	5
pageRange	712-714
publicationName	Hematological Oncology
startingPage	712
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_332e414602a4f905c4c7f577007d1bb1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eae1e8879326fee232ff0359e431195b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_849ade8d3b9724b4eba7583604c4e746
bibliographicCitation	Del Poeta G, Bomben R, Polesel J, Rossi FM, Pozzo F, Zaina E, Cattarossi I, Varaschin P, Nanni P, Boschian Boschin R, Postorino M, Laureana R, Pasqualone G, Steffan A, Gentile M, Zucchetto A, Gattei V. COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients. Hematological Oncology. 2021 Aug 30;39(5):712–4. doi: 10.1002/hon.2916.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7319bdef7c07ced9947f28e46f54df8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af9eb7aa95b3c51031e5b0bf51344bc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5c901965a605c9d962d261f25075e24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16b0c68bbb6a1625454d30be670705ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9742a10f96bb35ecc3a315427109c52f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5256-0726 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc4d16bcee0a7225a047de26b8718792 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5933-9680 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3678-5957 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb2cc9c65c8969ca29ec7c5100f39d5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4e00cd85adc0f77a58a1627b5ceaf50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c441bcbb0ed8bcfc825770c70581b01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11cb1d4be9ac9524de540108a965b719 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_880152bd603c5d96f8769f8f51e08f6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_799d2e5dcaee1fd3bf15b47c59d96159 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eecbd25d7993cbfebf10115c82c8f3c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8338097c0c30315e80eaf3ea3ff93c1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b89c762567f44fd4eaa42b0f1803c4d3
date	2021-08-30^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34462939 https://pubmed.ncbi.nlm.nih.gov/PMC8652757 https://doi.org/10.1002/hon.2916
isPartOf	https://portal.issn.org/resource/ISSN/1099-1069 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4074 https://portal.issn.org/resource/ISSN/0278-0232
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients
discusses	http://id.nlm.nih.gov/mesh/M0001361 http://id.nlm.nih.gov/mesh/M000732754
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000917Q000187 http://id.nlm.nih.gov/mesh/D000914Q000276 http://id.nlm.nih.gov/mesh/D015451Q000276 http://id.nlm.nih.gov/mesh/D014611Q000379 http://id.nlm.nih.gov/mesh/D000086382Q000276 http://id.nlm.nih.gov/mesh/D000086663Q000008 http://id.nlm.nih.gov/mesh/D000086402Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000086382Q000517 http://id.nlm.nih.gov/mesh/D015451Q000097 http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D000086382Q000821 http://id.nlm.nih.gov/mesh/D015451Q000821 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000086663Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000914Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762

Showing number of triples: 1 to 66 of 66.